Question

Julia's condition advances to severe preeclampsia and she is admitted to the hospital. A magnesium sulfate intravenous infusion is initiated. a. State the primary expected outcome associated with this medication.

Answer 1

The primary expected outcome associated with the intravenous infusion of magnesium sulfate in the treatment of severe preeclampsia is to prevent or manage seizures in the mother. Magnesium sulfate is often administered to pregnant individuals with severe preeclampsia as a prophylactic measure to reduce the risk of eclampsia, which is characterized by seizures. By controlling and preventing seizures, magnesium sulfate helps protect the health and safety of both the mother and the unborn baby during this critical medical situation.